// November 13, 2020
Breeding a superbug: how poor-quality medicines fuel AMR
Another public health crisis looms in the wake of the COVID-19 pandemic.
Another public health crisis looms in the wake of the COVID-19 pandemic.
To those in the pharmaceutical industry, USP may be both familiar and a little myster
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr
Over the past three decades, our medicines have become increasingly “globalized.” In the US alone